Stephen DiPalma

Stephen DiPalma

Director/Board Member bij Phytera, Inc.

66 jaar
Health Technology
Commercial Services
Health Services

Profiel

Stephen J.
DiPalma
is the founder of Blueprint Genetics, Inc. (founded in 1988) and Catalyst Oncology, Inc. (founded in 2004).
He held the title of Chief Financial Officer at Blueprint Genetics, Inc. from 1988 to 1995 and the title of President & Chief Executive Officer at Catalyst Oncology, Inc. Mr. DiPalma's current job(s) included being a Director at Phytera, Inc. since 1998 and a Co-Managing Director at Danforth Advisors LLC since 2014.
Mr. DiPalma's former job(s) include being a Director at Cognoptix, Inc., Chief Financial Officer at Aquila Biopharmaceuticals, Inc., Chief Financial Officer at Interleukin Genetics, Inc. from 2014 to 2017, Chief Financial Officer & Senior Vice President at FORUM Pharmaceuticals, Inc. from 2009 to 2014, Chief Financial Officer at Histogenics Corp.
in 2015, Chief Financial Officer & EVP-Business Operations at Galena Biopharma, Inc. in 2009, Chief Financial Officer at Scorpius Holdings, Inc., Chief Financial Officer at Anchiano Therapeutics Ltd.
in 2020, Chief Financial Officer at Milkhaus Laboratory, Inc. from 2002 to 2004, Divisional Controller at The Health Data Institute, Inc., Chief Financial Officer & Treasurer at Spero Therapeutics, Inc. from 2019 to 2021, Chief Financial Officer & Treasurer at Spero Therapeutics, Inc. in 2023, Chief Financial & Accounting Officer at Beyond Air, Inc. in 2018, Treasurer, Chief Financial & Accounting Officer at Solid Biosciences, Inc. from 2021 to 2023, Chief Financial & Accounting Officer at Inozyme Pharma, Inc., Chief Financial & Accounting Officer at Generation Bio Co. from 2019 to 2020, Chief Financial Officer at LAVA Therapeutics NV, Chief Financial Officer at CG Oncology, Inc., and Chief Financial Officer & Treasurer at Foghorn Therapeutics, Inc. in 2024.
Mr. DiPalma's education history includes an MBA from Babson College in 1988 and an undergraduate degree from the University of Massachusetts Lowell.

Actieve functies van Stephen DiPalma

BedrijvenFunctieBegin
Director/Board Member 01-01-1998
Corporate Officer/Principal 01-04-2014
Alle actieve functies van Stephen DiPalma

Eerdere bekende functies van Stephen DiPalma

BedrijvenFunctieEinde
FOGHORN THERAPEUTICS INC. Director of Finance/CFO 16-04-2024
SPERO THERAPEUTICS, INC. Director of Finance/CFO 06-11-2023
SOLID BIOSCIENCES INC. Director of Finance/CFO 09-01-2023
LAVA THERAPEUTICS N.V. Director of Finance/CFO 15-03-2021
SPERO THERAPEUTICS, INC. Director of Finance/CFO 04-01-2021
Ervaring van Stephen DiPalma in detail bekijken

Opleiding van Stephen DiPalma

Babson College Masters Business Admin
University of Massachusetts Lowell Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Stephen DiPalma in detail bekijken

Connecties

100 +

Eerstegraads connecties

24

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven9
SCORPIUS HOLDINGS, INC.

Health Technology

CG ONCOLOGY, INC.

Health Technology

SPERO THERAPEUTICS, INC.

Health Technology

BEYOND AIR, INC.

Health Technology

SOLID BIOSCIENCES INC.

Health Technology

INOZYME PHARMA, INC.

Health Technology

FOGHORN THERAPEUTICS INC.

Health Technology

GENERATION BIO CO.

Health Technology

LAVA THERAPEUTICS N.V.

Health Technology

Bedrijven in privébezit13

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Process Industries

Catalyst Oncology, Inc.

Health Services

The Health Data Institute, Inc.

Finance

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Stephen DiPalma